Page last updated: 2024-08-21

quinazolines and leptomycin b

quinazolines has been researched along with leptomycin b in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gao, W; Liu, Z	1

Other Studies

1 other study(ies) available for quinazolines and leptomycin b

Article	Year
Leptomycin B reduces primary and acquired resistance of gefitinib in lung cancer cells. Toxicology and applied pharmacology, 2017, 11-15, Volume: 335 Topics: A549 Cells; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Cell Cycle Checkpoints; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Epithelial-Mesenchymal Transition; ErbB Receptors; Fatty Acids, Unsaturated; Flow Cytometry; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Lung Neoplasms; Protein Kinase Inhibitors; Quinazolines; Signal Transduction; Survivin; Time Factors	2017

Article

Year

Leptomycin B reduces primary and acquired resistance of gefitinib in lung cancer cells.

Toxicology and applied pharmacology, 2017, 11-15, Volume: 335

Topics: A549 Cells; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Cell Cycle Checkpoints; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Epithelial-Mesenchymal Transition; ErbB Receptors; Fatty Acids, Unsaturated; Flow Cytometry; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Lung Neoplasms; Protein Kinase Inhibitors; Quinazolines; Signal Transduction; Survivin; Time Factors

2017